Original Article

Outcomes of Patients Hospitalized for Severe Acute Alcoholic Hepatitis

Authors: Leonard Noronha, MD, Erin FitzGerald, DO, J. Rush Pierce, MD, MPH


Objectives: Severe acute alcoholic hepatitis is a serious condition in individuals who consume significant quantities of alcohol. We aimed to identify risk factors for short-term mortality with this illness.

Methods: Patients with severe acute alcoholic hepatitis admitted to our academic medical center from 2010 to 2012 were identified. Demographic features, laboratory values, and patient outcomes were recorded. In-hospital mortality and transfer to inpatient hospice were combined to calculate overall inpatient mortality.

Results: A total of 251 hospitalizations of 191 patients were identified. The average age was 43.1 years (standard deviation 9.55). Most patients were men (80.6%). Compared with all adult patients admitted to internal medicine services during the same period, patients self-reporting Native American and Hispanic race/ethnicity were overrepresented (11.1% vs 34.0% and 14.8% vs 27.7%, χ2 P < 0.0001). In-hospital mortality was 20.3%. Another 10% of patients were transferred to inpatient hospice facilities. In the multivariate analysis, higher overall inpatient mortality was associated with an admission bilirubin >20 mg/dL (odds ratio 4.59). Of the patients, 11.9% were readmitted with a complication within 30 days—most commonly septic shock. Of the readmitted patients, the overall inpatient mortality was 86.2%.

Conclusions: This study confirms the severity of illness among patients with severe acute alcoholic hepatitis. Patients with the highest total bilirubin levels on admission had the highest overall inpatient mortality. Readmission was a strong predictor of overall in-hospital mortality.
Posted in: Gastroenterology39 Liver Disease3

This content is limited to qualifying members.

Existing members, please login first.

If you have an existing account please login now to access this article or view your purchase options.

Purchase only this article ($15)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.


1. Lucey MR, Mathurin P, Morgan TR. Alcoholic hepatitis. N Engl J Med 2009;360:2758-2769.
2. Amini M, Runyon BA. Alcoholic hepatitis 2010: a clinician’ guide to diagnosis and therapy. World J Gastroenterol 2010;16:4905-4912.
3. O’Shea RS, Dasarathy S, McCullough AJ, et al. Alcoholic liver disease. Hepatology 2010;51:307-328.
4. Liangpunsakul S. Clinical characteristics and mortality of hospitalized alcoholic hepatitis patients in the United States. J Clin Gastroenterol 2011;45:714-719.
5. Singal AK, Kamath PS, Gores GJ, et al. Alcoholic hepatitis: current challenges and future directions. Clin Gastroenterol Hepatol 2014;12:555-564.
6. European Association for the Study of the Liver. EASL clinical practical guidelines: management of alcoholic liver disease. J Hepatol 2012;57:399-420.
7. Singal AK, Bataller R, Ahn J, et al. ACG clinical guideline: alcoholic liver disease. Am J Gastroenterol 2018;113:175-194.
8. Thursz MR, Richardson P, Allison M, et al. Prednisolone or pentoxifylline for alcoholic hepatitis. N Engl J Med 2015;372:1619-1628.
9. Scott JD, Garland N. Chronic liver disease in Aboriginal North Americans. World J Gastroenterol 2008;14:4607-4615.
10. Shiels MS, Chernyavskiy P, Anderson WF, et al. Trends in premature mortality in the USA by sex, race, and ethnicity from 1999 to 2014: an analysis of death certificate data. Lancet 2017;389:1043-1054.
11. Desai AP, Mohan P, Roubal AM, et al. Geographic variability in liver-disease related mortality rates in the United States. Am J Med 2018;131:728-734.
12. Tapper EB, Parikh ND. Mortality due to cirrhosis and liver cancer in the United Sates, 1999-2016: observational study. BMJ 2018;362:k2817.
13. Bachman JG, Wallace JM, Jr O’Malley PM, et al. Racial/ethnic differences in smoking, drinking, and illicit drug use among American high school seniors, 1976-89. Am J Public Health 1991;81:372-377.
14. Gilman SE, Breslau J, Conron KJ, et al. Education and race-ethnicity differences in the lifetime risk of alcohol dependence. J Epidemiol Community Health 2008;62:224-230.
15. Fischer GE, Bialek SP, Homan CE, et al. Chronic liver disease among Alaska-Native people, 2003-2004. Am J Gastroenterol 2009;104:363-370.
16. Setiawan VW, Stram DO, Porcel J, et al. Prevalence of chronic liver disease and cirrhosis by underlying cause in understudied ethnic groups: the multiethnic cohort. Hepatology 2016;64:1969-1977.
17. Abbasi J. Why are American Indians dying young? JAMA 2018;:339:109-111.
18. New Mexico Hepatitis C Coalition. Hepatitis C virus (HCV) in New Mexico: statewide comprehensive plan and profile of the epidemic. https://nmhealth.org/publication/view/plan/2219. Published June 2016. Accessed August 1, 2018.
19. Rempel JD, Uhanova J. Hepatitis C virus in American Indian/Alaskan Native and Aboriginal peoples of North America. Viruses 2012;4:3912-3931.
20. Jinjuvadia R, Liangpunsakul S, Translational Research and Evolving Hepatitis Treatment Consortium. Trends in alcoholic hepatitis-related hospitalizations, financial burden, and mortality in the United States. J Clin Gastroenterol 2015;49:506-511.